 Mehdi Fini
Concepts (228)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Xanthine Dehydrogenase | 6 | 2017 | 34 | 1.590 |
Why?
| | Hyperuricemia | 1 | 2022 | 134 | 0.740 |
Why?
| | Urate Oxidase | 1 | 2019 | 30 | 0.700 |
Why?
| | Gout | 1 | 2019 | 57 | 0.670 |
Why?
| | Hypertension, Pulmonary | 8 | 2021 | 1794 | 0.530 |
Why?
| | Fibroblasts | 6 | 2021 | 842 | 0.520 |
Why?
| | Polyethylene Glycols | 1 | 2019 | 578 | 0.500 |
Why?
| | Adrenergic alpha-1 Receptor Agonists | 1 | 2013 | 5 | 0.470 |
Why?
| | Veins | 1 | 2013 | 60 | 0.450 |
Why?
| | Cause of Death | 1 | 2014 | 380 | 0.420 |
Why?
| | Vasoconstriction | 1 | 2013 | 213 | 0.420 |
Why?
| | Uric Acid | 5 | 2023 | 354 | 0.400 |
Why?
| | Alcoholism | 1 | 2017 | 717 | 0.390 |
Why?
| | Cell Movement | 4 | 2017 | 896 | 0.380 |
Why?
| | Overweight | 1 | 2014 | 502 | 0.370 |
Why?
| | Hydrogen Peroxide | 2 | 2022 | 305 | 0.340 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2174 | 0.320 |
Why?
| | Breast Neoplasms | 2 | 2011 | 1965 | 0.320 |
Why?
| | Vascular Remodeling | 2 | 2020 | 152 | 0.320 |
Why?
| | Lung | 4 | 2017 | 3664 | 0.300 |
Why?
| | Macrophage Activation | 2 | 2021 | 168 | 0.300 |
Why?
| | Enzyme Inhibitors | 3 | 2022 | 827 | 0.270 |
Why?
| | Pulmonary Artery | 5 | 2020 | 1063 | 0.270 |
Why?
| | Hypertension | 1 | 2013 | 1203 | 0.250 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2008 | 1167 | 0.220 |
Why?
| | Cardiovascular Diseases | 1 | 2014 | 1798 | 0.210 |
Why?
| | Hypoxia | 3 | 2020 | 963 | 0.210 |
Why?
| | Cells, Cultured | 7 | 2021 | 4077 | 0.200 |
Why?
| | Obesity | 1 | 2014 | 2746 | 0.200 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2021 | 97 | 0.190 |
Why?
| | Cellular Microenvironment | 1 | 2021 | 79 | 0.190 |
Why?
| | Macrophages, Alveolar | 2 | 2021 | 359 | 0.180 |
Why?
| | Macrophages | 2 | 2019 | 1324 | 0.180 |
Why?
| | Mammary Glands, Human | 2 | 2011 | 61 | 0.180 |
Why?
| | Doxorubicin | 1 | 2021 | 302 | 0.180 |
Why?
| | Lipopolysaccharides | 2 | 2017 | 870 | 0.170 |
Why?
| | Animals | 20 | 2021 | 33381 | 0.170 |
Why?
| | Familial Primary Pulmonary Hypertension | 2 | 2016 | 193 | 0.160 |
Why?
| | Ventricular Remodeling | 1 | 2020 | 229 | 0.160 |
Why?
| | Cell Line, Tumor | 4 | 2021 | 2851 | 0.160 |
Why?
| | Neprilysin | 1 | 2017 | 48 | 0.150 |
Why?
| | Humans | 20 | 2023 | 118972 | 0.150 |
Why?
| | Bronchoalveolar Lavage | 1 | 2017 | 89 | 0.150 |
Why?
| | rho GTP-Binding Proteins | 1 | 2017 | 65 | 0.150 |
Why?
| | Luteolin | 1 | 2017 | 4 | 0.150 |
Why?
| | Cell Proliferation | 3 | 2017 | 2275 | 0.150 |
Why?
| | Oxidative Stress | 3 | 2021 | 1178 | 0.150 |
Why?
| | Hemoglobins | 1 | 2019 | 326 | 0.150 |
Why?
| | Alzheimer Disease | 1 | 2023 | 513 | 0.150 |
Why?
| | Complement Activation | 1 | 2020 | 350 | 0.150 |
Why?
| | Epithelial Cells | 3 | 2007 | 963 | 0.150 |
Why?
| | Cyclooxygenase 2 | 1 | 2017 | 168 | 0.150 |
Why?
| | Fructokinases | 1 | 2017 | 63 | 0.150 |
Why?
| | Mice, Inbred C57BL | 6 | 2021 | 4908 | 0.150 |
Why?
| | Mammary Glands, Animal | 2 | 2008 | 124 | 0.140 |
Why?
| | Rats | 9 | 2021 | 5392 | 0.140 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2017 | 150 | 0.140 |
Why?
| | Anemia, Sickle Cell | 1 | 2019 | 230 | 0.140 |
Why?
| | Alcohol Oxidoreductases | 1 | 2016 | 57 | 0.140 |
Why?
| | Muscle Proteins | 1 | 2017 | 219 | 0.140 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2017 | 236 | 0.140 |
Why?
| | Immunoglobulin G | 1 | 2020 | 788 | 0.130 |
Why?
| | Pneumonia | 4 | 2010 | 592 | 0.130 |
Why?
| | Interleukin-1beta | 1 | 2017 | 379 | 0.130 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2017 | 454 | 0.130 |
Why?
| | Mice | 8 | 2021 | 15520 | 0.120 |
Why?
| | Insulin Resistance | 1 | 2023 | 1180 | 0.120 |
Why?
| | Vasculitis | 1 | 2014 | 75 | 0.120 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2014 | 246 | 0.110 |
Why?
| | Cattle | 4 | 2021 | 978 | 0.110 |
Why?
| | Blood Pressure | 1 | 2019 | 1664 | 0.110 |
Why?
| | Osteopontin | 1 | 2012 | 39 | 0.110 |
Why?
| | Inhibitor of Differentiation Protein 1 | 1 | 2011 | 7 | 0.100 |
Why?
| | Genes, erbB-2 | 1 | 2011 | 27 | 0.100 |
Why?
| | Male | 11 | 2021 | 57801 | 0.100 |
Why?
| | Apoptosis | 1 | 2021 | 2484 | 0.100 |
Why?
| | Microarray Analysis | 1 | 2011 | 124 | 0.100 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 2 | 2014 | 35 | 0.100 |
Why?
| | Rats, Sprague-Dawley | 6 | 2021 | 2478 | 0.100 |
Why?
| | Mice, Knockout | 4 | 2020 | 2680 | 0.100 |
Why?
| | Disease Models, Animal | 3 | 2020 | 3730 | 0.100 |
Why?
| | STAT3 Transcription Factor | 2 | 2014 | 189 | 0.090 |
Why?
| | Phagocytes | 1 | 2010 | 91 | 0.090 |
Why?
| | Female | 7 | 2021 | 61564 | 0.090 |
Why?
| | Phenotype | 5 | 2017 | 3003 | 0.090 |
Why?
| | Acute Kidney Injury | 1 | 2017 | 709 | 0.090 |
Why?
| | Mice, Nude | 1 | 2011 | 663 | 0.090 |
Why?
| | Cytokines | 2 | 2007 | 1900 | 0.090 |
Why?
| | Chemokines | 1 | 2010 | 230 | 0.090 |
Why?
| | PPAR gamma | 1 | 2010 | 188 | 0.090 |
Why?
| | Kidney | 1 | 2017 | 1353 | 0.090 |
Why?
| | DNA-Binding Proteins | 1 | 2016 | 1346 | 0.090 |
Why?
| | RNA, Small Interfering | 1 | 2011 | 564 | 0.090 |
Why?
| | Transfection | 2 | 2008 | 888 | 0.080 |
Why?
| | Leukocytes | 2 | 2007 | 290 | 0.080 |
Why?
| | Fructose | 2 | 2023 | 204 | 0.080 |
Why?
| | DNA, Complementary | 1 | 2008 | 268 | 0.080 |
Why?
| | Culture Media, Conditioned | 2 | 2021 | 112 | 0.080 |
Why?
| | Integrin alpha4beta1 | 1 | 2007 | 7 | 0.080 |
Why?
| | Lymphocyte Function-Associated Antigen-1 | 1 | 2007 | 35 | 0.080 |
Why?
| | Flavonoids | 1 | 2007 | 71 | 0.080 |
Why?
| | Cell Differentiation | 2 | 2011 | 1753 | 0.070 |
Why?
| | MicroRNAs | 1 | 2013 | 637 | 0.070 |
Why?
| | Rats, Wistar | 2 | 2021 | 399 | 0.070 |
Why?
| | Enzyme Activation | 3 | 2017 | 828 | 0.070 |
Why?
| | Receptors, Glucocorticoid | 1 | 2007 | 133 | 0.070 |
Why?
| | Cell Adhesion | 1 | 2007 | 443 | 0.070 |
Why?
| | alpha-Tocopherol | 1 | 2005 | 24 | 0.070 |
Why?
| | Quinacrine | 1 | 2004 | 8 | 0.060 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2006 | 285 | 0.060 |
Why?
| | Ferritins | 1 | 2004 | 61 | 0.060 |
Why?
| | Cell Hypoxia | 2 | 2014 | 220 | 0.050 |
Why?
| | Stress, Physiological | 1 | 2006 | 415 | 0.050 |
Why?
| | Activating Transcription Factor 6 | 1 | 2021 | 18 | 0.050 |
Why?
| | Signal Transduction | 4 | 2017 | 4709 | 0.050 |
Why?
| | Cardiotoxicity | 1 | 2021 | 29 | 0.050 |
Why?
| | Transcription Factor CHOP | 1 | 2021 | 29 | 0.050 |
Why?
| | Inflammation | 3 | 2020 | 2566 | 0.050 |
Why?
| | Cell Line | 3 | 2017 | 2707 | 0.050 |
Why?
| | Lung Diseases | 1 | 2007 | 718 | 0.050 |
Why?
| | Coculture Techniques | 1 | 2021 | 208 | 0.050 |
Why?
| | Cellular Reprogramming | 1 | 2021 | 85 | 0.050 |
Why?
| | Hemorrhage | 1 | 2004 | 623 | 0.050 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2021 | 190 | 0.050 |
Why?
| | Complement C5 | 1 | 2020 | 75 | 0.050 |
Why?
| | Immunoglobulins | 1 | 2020 | 154 | 0.040 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2020 | 143 | 0.040 |
Why?
| | Gadolinium | 1 | 2019 | 79 | 0.040 |
Why?
| | Complement Factor B | 1 | 2020 | 102 | 0.040 |
Why?
| | Endoplasmic Reticulum | 1 | 2021 | 241 | 0.040 |
Why?
| | Complement Pathway, Alternative | 1 | 2020 | 117 | 0.040 |
Why?
| | Complement C3 | 1 | 2020 | 192 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2021 | 576 | 0.040 |
Why?
| | Chemokine CXCL1 | 2 | 2010 | 69 | 0.040 |
Why?
| | Adult | 2 | 2017 | 31512 | 0.040 |
Why?
| | ets-Domain Protein Elk-1 | 1 | 2017 | 14 | 0.040 |
Why?
| | Smooth Muscle Myosins | 1 | 2017 | 9 | 0.040 |
Why?
| | Metabolome | 1 | 2021 | 296 | 0.040 |
Why?
| | Cardiomyopathies | 1 | 2021 | 299 | 0.040 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2017 | 56 | 0.040 |
Why?
| | Glucose | 1 | 2023 | 953 | 0.040 |
Why?
| | Insulin | 1 | 2007 | 2162 | 0.040 |
Why?
| | Middle Aged | 1 | 2017 | 27617 | 0.040 |
Why?
| | Microfilament Proteins | 1 | 2017 | 134 | 0.040 |
Why?
| | Protective Agents | 1 | 2017 | 42 | 0.040 |
Why?
| | Myocytes, Cardiac | 1 | 2021 | 472 | 0.040 |
Why?
| | Aldehyde Reductase | 1 | 2017 | 101 | 0.040 |
Why?
| | Adventitia | 1 | 2016 | 39 | 0.040 |
Why?
| | Calcium-Binding Proteins | 1 | 2017 | 217 | 0.040 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 2007 | 332 | 0.040 |
Why?
| | Endothelin-1 | 1 | 2017 | 168 | 0.030 |
Why?
| | Genes, Reporter | 2 | 2007 | 270 | 0.030 |
Why?
| | Actins | 1 | 2017 | 404 | 0.030 |
Why?
| | Transcriptome | 1 | 2021 | 756 | 0.030 |
Why?
| | Mitochondria | 1 | 2021 | 786 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2020 | 727 | 0.030 |
Why?
| | Rats, Inbred WKY | 1 | 2014 | 38 | 0.030 |
Why?
| | Polypyrimidine Tract-Binding Protein | 1 | 2013 | 15 | 0.030 |
Why?
| | Blotting, Western | 2 | 2007 | 1194 | 0.030 |
Why?
| | Immunoblotting | 1 | 2014 | 307 | 0.030 |
Why?
| | Ischemia | 1 | 2017 | 374 | 0.030 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 69 | 0.030 |
Why?
| | Chemokine CCL2 | 1 | 2013 | 126 | 0.030 |
Why?
| | Receptor, Notch1 | 1 | 2013 | 65 | 0.030 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2013 | 109 | 0.030 |
Why?
| | 3' Untranslated Regions | 1 | 2013 | 142 | 0.030 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 182 | 0.030 |
Why?
| | Cell Growth Processes | 1 | 2012 | 54 | 0.030 |
Why?
| | Integrin alphaVbeta3 | 1 | 2012 | 25 | 0.030 |
Why?
| | Neutrophils | 2 | 2010 | 1233 | 0.030 |
Why?
| | Genotype | 1 | 2017 | 1882 | 0.030 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2005 | 613 | 0.030 |
Why?
| | Disease Progression | 1 | 2019 | 2490 | 0.030 |
Why?
| | Promoter Regions, Genetic | 2 | 2007 | 1158 | 0.030 |
Why?
| | Hyaluronan Receptors | 1 | 2012 | 93 | 0.030 |
Why?
| | Histone Deacetylases | 1 | 2013 | 198 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2014 | 806 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 982 | 0.030 |
Why?
| | Fibrosis | 1 | 2014 | 483 | 0.030 |
Why?
| | Prognosis | 1 | 2020 | 3443 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2014 | 1206 | 0.020 |
Why?
| | U937 Cells | 1 | 2010 | 26 | 0.020 |
Why?
| | HL-60 Cells | 1 | 2010 | 29 | 0.020 |
Why?
| | Sumoylation | 1 | 2010 | 16 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2012 | 536 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2012 | 462 | 0.020 |
Why?
| | Epigenesis, Genetic | 1 | 2014 | 539 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2012 | 292 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2014 | 688 | 0.020 |
Why?
| | Th1 Cells | 1 | 2010 | 133 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2012 | 420 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 1137 | 0.020 |
Why?
| | Gene Expression | 1 | 2014 | 1489 | 0.020 |
Why?
| | Protein Binding | 1 | 2013 | 1975 | 0.020 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2007 | 42 | 0.020 |
Why?
| | Tissue Fixation | 1 | 2007 | 32 | 0.020 |
Why?
| | Phosphorylation | 1 | 2012 | 1633 | 0.020 |
Why?
| | Mifepristone | 1 | 2007 | 65 | 0.020 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2007 | 112 | 0.020 |
Why?
| | Hormone Antagonists | 1 | 2007 | 41 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2013 | 1323 | 0.020 |
Why?
| | MAP Kinase Kinase Kinases | 1 | 2007 | 71 | 0.020 |
Why?
| | Neoplasms | 1 | 2021 | 2179 | 0.020 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2007 | 175 | 0.020 |
Why?
| | Cycloheximide | 1 | 2006 | 57 | 0.020 |
Why?
| | Enzyme Induction | 1 | 2006 | 94 | 0.020 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2006 | 47 | 0.020 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2006 | 76 | 0.020 |
Why?
| | Luciferases | 1 | 2006 | 143 | 0.020 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2006 | 136 | 0.020 |
Why?
| | Phagocytosis | 1 | 2007 | 364 | 0.020 |
Why?
| | Dexamethasone | 1 | 2007 | 320 | 0.020 |
Why?
| | Chemokines, CXC | 1 | 2005 | 64 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2006 | 363 | 0.020 |
Why?
| | Pulmonary Alveoli | 1 | 2007 | 384 | 0.020 |
Why?
| | Monocytes | 1 | 2007 | 513 | 0.020 |
Why?
| | Oxidants | 1 | 2004 | 122 | 0.020 |
Why?
| | Cell Culture Techniques | 1 | 2006 | 356 | 0.010 |
Why?
| | Administration, Inhalation | 1 | 2005 | 656 | 0.010 |
Why?
| | Trachea | 1 | 2005 | 226 | 0.010 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2005 | 369 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2007 | 1691 | 0.010 |
Why?
| | Glucocorticoids | 1 | 2007 | 545 | 0.010 |
Why?
| | Cell Nucleus | 1 | 2006 | 580 | 0.010 |
Why?
| | Binding Sites | 1 | 2006 | 1224 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2005 | 1171 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2005 | 2657 | 0.010 |
Why?
| | Mutation | 1 | 2006 | 3457 | 0.010 |
Why?
|
|
Fini's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|